EQT Private Equity and Goldman Sachs Asset Management to acquire Parexel, a leading global clinical research organization, for USD 8.5 billion
· Parexel is a leading global provider of clinical research and consulting services to the pharma and biotech industry · Parexel’s services enable the development of innovative new medicines that improve the health of patients across the world · EQT Private Equity and Goldman Sachs Asset Management are committed to making significant investments to further Parexel’s offering, including best-in-class service delivery, quality, and client focus The EQT IX fund (“EQT Private Equity”) and the Private Equity business within Goldman Sachs Asset Management (“Goldman Sachs”) have